These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37106204)
1. Imaging CAR-T Synapse as a Quality Control for CAR Engineering. Xiao Q; Su X Methods Mol Biol; 2023; 2654():503-512. PubMed ID: 37106204 [TBL] [Abstract][Full Text] [Related]
2. Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells. Xiong W; Chen Y; Kang X; Chen Z; Zheng P; Hsu YH; Jang JH; Qin L; Liu H; Dotti G; Liu D Mol Ther; 2018 Apr; 26(4):963-975. PubMed ID: 29503199 [TBL] [Abstract][Full Text] [Related]
3. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors. Kosti P; Maher J; Arnold JN Front Immunol; 2018; 9():1104. PubMed ID: 29872437 [TBL] [Abstract][Full Text] [Related]
4. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641 [No Abstract] [Full Text] [Related]
5. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives. Gauthier J; Yakoub-Agha I Curr Res Transl Med; 2017 Sep; 65(3):93-102. PubMed ID: 28988742 [TBL] [Abstract][Full Text] [Related]
6. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy. Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053 [TBL] [Abstract][Full Text] [Related]
7. Strategies to overcome the side effects of chimeric antigen receptor T cell therapy. Mirzaee Godarzee M; Mahmud Hussen B; Razmara E; Hakak-Zargar B; Mohajerani F; Dabiri H; Fatih Rasul M; Ghazimoradi MH; Babashah S; Sadeghizadeh M Ann N Y Acad Sci; 2022 Apr; 1510(1):18-35. PubMed ID: 34982476 [TBL] [Abstract][Full Text] [Related]
8. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. Zhang E; Gu J; Xu H Mol Cancer; 2018 Jan; 17(1):7. PubMed ID: 29329591 [TBL] [Abstract][Full Text] [Related]
9. Engineering CAR-T Cells for Next-Generation Cancer Therapy. Hong M; Clubb JD; Chen YY Cancer Cell; 2020 Oct; 38(4):473-488. PubMed ID: 32735779 [TBL] [Abstract][Full Text] [Related]
10. Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse. Zang H; Siddiqui M; Gummuluru S; Wong WW; Reinhard BM ACS Nano; 2022 Nov; 16(11):18408-18420. PubMed ID: 36282488 [TBL] [Abstract][Full Text] [Related]
11. Methods of Machine Learning-Based Chimeric Antigen Receptor Immunological Synapse Quality Quantification. Gan J; Cho JH; Lee R; Naghizadeh A; Poon LY; Wang E; Hui Z; Liu D Methods Mol Biol; 2023; 2654():493-502. PubMed ID: 37106203 [TBL] [Abstract][Full Text] [Related]
12. Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells. Gao Z; Tong C; Wang Y; Chen D; Wu Z; Han W J Genet Genomics; 2019 Aug; 46(8):367-377. PubMed ID: 31466926 [TBL] [Abstract][Full Text] [Related]
13. CAR T-cell therapy: Full speed ahead. Sermer D; Brentjens R Hematol Oncol; 2019 Jun; 37 Suppl 1():95-100. PubMed ID: 31187533 [TBL] [Abstract][Full Text] [Related]
14. Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells. Wu L; Wei Q; Brzostek J; Gascoigne NRJ Cell Mol Immunol; 2020 Jun; 17(6):600-612. PubMed ID: 32451454 [TBL] [Abstract][Full Text] [Related]
15. Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology. Watanabe K; Kuramitsu S; Posey AD; June CH Front Immunol; 2018; 9():2486. PubMed ID: 30416506 [TBL] [Abstract][Full Text] [Related]
16. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment. Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390 [TBL] [Abstract][Full Text] [Related]
18. Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Salzer B; Schueller CM; Zajc CU; Peters T; Schoeber MA; Kovacic B; Buri MC; Lobner E; Dushek O; Huppa JB; Obinger C; Putz EM; Holter W; Traxlmayr MW; Lehner M Nat Commun; 2020 Aug; 11(1):4166. PubMed ID: 32820173 [TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer. Zhang BL; Li D; Gong YL; Huang Y; Qin DY; Jiang L; Liang X; Yang X; Gou HF; Wang YS; Wei YQ; Wang W Hum Gene Ther; 2019 Apr; 30(4):402-412. PubMed ID: 30693795 [TBL] [Abstract][Full Text] [Related]
20. Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". Teppert K; Wang X; Anders K; Evaristo C; Lock D; Künkele A Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]